Singapore markets open in 5 minutes

Humacyte, Inc. (HUMA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.5400+0.1300 (+2.95%)
At close: 04:00PM EDT
4.5500 +0.01 (+0.22%)
After hours: 07:43PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 525.16M
Enterprise value 463.62M
Trailing P/E 1.09
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)38.77
Enterprise value/revenue N/A
Enterprise value/EBITDA -4.81

Trading information

Stock price history

Beta (5Y monthly) 1.45
52-week change 3-11.47%
S&P500 52-week change 322.38%
52-week high 35.6000
52-week low 31.9600
50-day moving average 33.5071
200-day moving average 33.1271

Share statistics

Avg vol (3-month) 31.43M
Avg vol (10-day) 31.82M
Shares outstanding 5119.08M
Implied shares outstanding 6119.08M
Float 881.64M
% held by insiders 131.42%
% held by institutions 115.56%
Shares short (15 Apr 2024) 43.94M
Short ratio (15 Apr 2024) 43.54
Short % of float (15 Apr 2024) 44.37%
Short % of shares outstanding (15 Apr 2024) 43.31%
Shares short (prior month 15 Mar 2024) 43.78M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-36.44%
Return on equity (ttm)-169.80%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -89.22M
Net income avi to common (ttm)-110.78M
Diluted EPS (ttm)-1.1000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)80.45M
Total cash per share (mrq)0.68
Total debt (mrq)19.48M
Total debt/equity (mrq)143.84%
Current ratio (mrq)4.51
Book value per share (mrq)0.13

Cash flow statement

Operating cash flow (ttm)-73.31M
Levered free cash flow (ttm)-45.34M